[HTML][HTML] The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis
JM Grichnik, JA Burch, J Burchette, CR Shea - Journal of Investigative …, 1998 - Elsevier
JM Grichnik, JA Burch, J Burchette, CR Shea
Journal of Investigative Dermatology, 1998•ElsevierDuring development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical
for the survival of melanocytes. Limited in vivo human studies have suggested a possible
activating role of SCF on adult human melanocytes. In order to study the impact of this
pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial
injections of recombinant human SCF or a KIT-inhibitory antibody (K44. 2). On histologic
evaluation, SCF injection increased, whereas KIT inhibition decreased the number, size …
for the survival of melanocytes. Limited in vivo human studies have suggested a possible
activating role of SCF on adult human melanocytes. In order to study the impact of this
pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial
injections of recombinant human SCF or a KIT-inhibitory antibody (K44. 2). On histologic
evaluation, SCF injection increased, whereas KIT inhibition decreased the number, size …
During development, the interaction of stem cell factor (SCF) with its receptor, KIT, is critical for the survival of melanocytes. Limited in vivo human studies have suggested a possible activating role of SCF on adult human melanocytes. In order to study the impact of this pathway on normal melanocyte homeostasis, human skin xenografts were treated with serial injections of recombinant human SCF or a KIT-inhibitory antibody (K44.2). On histologic evaluation, SCF injection increased, whereas KIT inhibition decreased the number, size, and dendricity of melanocytes. Immunohistochemical expression of melanocyte differentiation antigens, including tyrosinase-relatedprotein-1 and gp100/pmel17, was markedly increased by treatment with SCF, and decreased by K44.2 treatment. The number of Ki67-positive melanocytes was increased in the SCF-treated tissue, suggesting a direct proliferative effect of SCF; conversely, treatment with K44.2 resulted in melanocyte loss, which did not appear reversible with prolonged treatment. These findings demonstrate that the SCF/KIT pathway remains critical in adult human skin, and that pharmacologic modulation of this single pathway can control cutaneous melanocyte homeostasis.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果